AQR Capital Management
LNAI

AQR Capital Management’s Lunai Bioworks LNAI Stock Holding History

AQR Capital Management’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-130
Closed -$3.01K – 3568
2025
Q2 		$3.01K Sell
130
-120
-48% -$3.35K ﹤0.01% 3292
2025
Q1 		$10.9K Buy
250
+119
+91% +$7.62K ﹤0.01% 3144
2024
Q4 		$8.76K Buy
+131
New +$8.69K ﹤0.01% 2856
2023
Q1 		– Sell
-260
Closed -$21.4K – 2239
2022
Q4 		$21.4K Sell
260
-63
-20% -$8.46K ﹤0.01% 2181
2022
Q3 		$47K Buy
+323
New +$58.9K ﹤0.01% 2150

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AQR Capital Management's LNAI Position: Q3 2025 in Review

AQR Capital Management sold out of Lunai Bioworks (LNAI) in Q3 2025, closing a stake of 130 shares — an estimated $3.01K sold.

AQR Capital Management first reported a position in LNAI in Q3 2022 and held it in 5 quarters. The position peaked at $47K in Q3 2022. 20 funds tracked by Wall St. Rank hold LNAI as of Q3 2025.

  • AQR Capital Management reported no remaining Lunai Bioworks position as of Q3 2025 after selling out during the quarter.
  • AQR Capital Management sold 130 Lunai Bioworks shares in Q3 2025, an estimated $3.01K.
  • AQR Capital Management first reported a position in Lunai Bioworks in Q3 2022 and held it in 5 quarters.
  • AQR Capital Management's Lunai Bioworks position peaked at $47K in Q3 2022.
  • 20 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.